Health Secretary Robert F. Kennedy Jr.'s decision this week to cancel hundreds of millions of dollars in mRNA vaccine funding ...

Latest move to cut funding for vaccines is not down to US health secretary. It is part of Trump’s wider war on science.

An official overseeing implementation of the Make America Healthy Again agenda at the Department of Health and Human Services ...

Intel has stood by Tan, and in a statement told The Wall Street Journal that its board and management were aligned on strategy. Before Trump jumped into the fray, Tan was already at odds with some of ...

Last week, President Trump sent letters to 17 major pharmaceutical companies advising them to work with his administration to ...

The FTSE 100 edged down on Friday on a mixed day for European equities despite new optimism about an end to the war between ...

CSL Seqirus was one of the drugmakers the federal government listed this week as having its mRNA-related work cut. In an ...

The U.S. government has been discussing with drugmakers how to raise overseas drug prices as President Donald Trump seeks to implement his Most Favored Nation policy, which attempts to lower U.S. drug ...

SERB Pharmaceuticals plans to buy Y-mAbs Pharmaceuticals in a $412 million all-cash deal. CorMedix bought Melinta ...

US Health Secretary Robert F. Kennedy Jr. has slashed government spending on mRNA vaccine research. Experts warn it will ...

The president who ran on his business acumen isn’t holding back in telling corporate bosses how to run their companies—or ...

American shoppers hit with 60% of costs as import taxes reach 100-year high - Tariffs on U.S. trading partners finally in full effect months after ‘Liberation Day’ announcement and ensuing turmoil and ...